Advertisement
<< Back To Article
Enanta’s New NS5A Inhibitor Shows Early Promise Against Hep C
Write a Comment
1 Comments
Advertisement
Zsuzsanna Snarey
I am very hopeful that this drug will be available soon and will not be priced too high for NHS England. A single dose to cure me seems like the perfect answer. I have Hepatitis C genotype 1b and I have mild Fibrosis. F1-2. Fibroscan 8.1 This means that I do not deserve treatment until I develop cirrhosis. This seems very unfair!
October 25, 2015 • Sandwich